BRO vs LAB · P/E 30, rev $4.80B vs rev $174.4M
Brown & Brown Inc (BRO) versus Standard Biotools Inc (LAB) — a side-by-side from cached financials, not a winner call.
Brown & Brown Inc (BRO) is a insurance brokers company listed on US.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
Latest reported BRO revenue for 2024-12-31 was $4.80B. Net income was $1.00B. Revenue was up 12.9% from 2023-12-31 to 2024-12-31. BRO currently screens at market cap $35.56B and trailing P/E 30.0.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
BRO currently screens at market cap $35.56B and trailing P/E 30.0. LAB currently screens at market cap $317.1M.
Not investment advice. Open the BRO and LAB stock pages for the full models.
Not investment advice.